Avoidance of transient cardiomyopathy in Cardiomyocyte-targeted Tamoxifen-induced mercremer gene deletion models

Circulation Research

Volumn 105, Issue 1, 2009, Pages 12-15

  Koitabashi, Norimichi ^a   Bedja, Djahida ^a   Zaiman, Ari L ^b   Pinto, Yigal M ^c   Zhang, Manling ^a   Gabrielson, Kathleen L ^a   Takimoto, Eiki ^a   Kassz, David A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cre recombinase; Inducible transgenic; Mouse models; Selective estrogen receptor modulator; Ventricular function

Indexed keywords

CRE RECOMBINASE; MYOSIN HEAVY CHAIN ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; RALOXIFENE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TAMOXIFEN; INTEGRASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; GENE; GENE CONTROL; GENE DELETION; GENE EXPRESSION; LOXP SITE; MERCREMER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; ACTIVE TRANSPORT; ANIMAL; CONGESTIVE CARDIOMYOPATHY; DRUG EFFECT; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HEART MUSCLE CELL; METABOLISM; TRANSGENIC MOUSE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CARDIOMYOPATHY, DILATED; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; INTEGRASES; MICE; MICE, TRANSGENIC; MYOCYTES, CARDIAC; TAMOXIFEN;

EID: 67949100572     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.198416     Document Type: Article

References (15)

1. Glaser S, Anastassiadis K, Stewart AF. Current issues in mouse genome engineering. Nat Genet. 2005;37:1187-1193.
2. O'Neal KR, Agah R. Conditional targeting: inducible deletion by Cre recombinase. Methods Mol Biol. 2007;366:309-320.
3. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, Penninger JM, Molkentin JD. Temporally regulated and tissuespecific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res. 2001;89:20-25.
4. Silver DP, Livingston DM. Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell. 2001;8:233-243.
5. Schmidt-Supprian M, Rajewsky K. Vagaries of conditional gene targeting. Nat Immunol. 2007;8:665-668.
6. Molkentin JD, Robbins J. With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure. J Mol Cell Cardiol. 2009;46:130-136.
7. Huss JM, Kelly DP. Nuclear receptor signaling and cardiac energetics. Circ Res. 2004;95:568-578.
8. Sihag S, Cresci S, Li AY, Sucharov CC, Lehman JJ. PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol. 2009;46:201-212.
9. Greschik H, Flaig R, Renaud JP, Moras D. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity. J Biol Chem. 2004;279:33639-33646.
10. Shang Y, Brown M. Molecular determinants for the tissue specificity of SERMs. Science. 2002;295:2465-2468.
11. Paulmurugan R, Gambhir SS. An intramolecular folding sensor for imaging estrogen receptor-ligand interactions. Proc Natl Acad Sci U S A. 2006;103:15883-15888.
12. Kiermayer C, Conrad M, Schneider M, Schmidt J, Brielmeier M. Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen citrate. Genesis. 2007;45:11-16.
13. Dufour CR, Wilson BJ, Huss JM, Kelly DP, Alaynick WA, Downes M, Evans RM, Blanchette M, Giguere V. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab. 2007;5:345-356.
14. Cohen IR, Sims ML, Robbins MR, Lakshmanan MC, Francis PC, Long GG. The reversible effects of raloxifene on luteinizing hormone levels and ovarian morphology in mice. Reprod Toxicol. 2000;14:37-44.
15. Ogita H, Node K, Liao Y, Ishikura F, Beppu S, Asanuma H, Sanada S, Takashima S, Minamino T, Hori M, Kitakaze M. Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice. Hypertension. 2004;43:237-242.